- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03847402
The Early Integrated Intervention for Child Brain-developmental Disorders in China
January 6, 2022 updated by: Children's Hospital of Fudan University
The Multi-site Study of the Early Integrated Intervention for Child Brain-developmental Disorders in China
This study is focused on developing the early integrated intervention for child brain-developmental disorders, including globe developmental delay (GDD), autism spectrum disorder (ASD), and attention deficit-hyperactivity disorder (ADHD), in China.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The early integrated intervention of GDD and ASD is developed by Children's Hospital of Fudan University.
The early integrated intervention of ADHD is developed by Nanjing Brain Hospital.
Study Type
Interventional
Enrollment (Actual)
900
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201102
- Children's Hospital of Fudan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 months to 3 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- GDD: IQ<70, in more than 2 areas of development;
- ASD: Diagnose must meet the criteria of DSM-V;
- ADHD: Diagnose must meet the criteria of DSM-V, and IQ>70 tested by Wechsler Intelligence Scale;
- At least one of the parents could take part in the whole courses, and do the training at home.
Exclusion Criteria:
- Physical disability, visual or hearing loss;
- Combined other sever chronic diseases: liver or kidney function failure, rheumatic diseases, or tumor, and so on;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: GDD intervention
The early integrated intervention for GDD
|
The early integrated intervention for GDD integrates developmental approaches with strategies of applied behavior analysis.
|
ACTIVE_COMPARATOR: GDD non-intervention
Community intervention for GDD
|
community intervention based on developmental approaches
|
EXPERIMENTAL: ASD intervention
The early integrated intervention for ASD
|
The theoretical underpinnings of the early integrated intervention for ASD originate from Early Start Denver Model.
|
ACTIVE_COMPARATOR: ASD non-intervention
Community intervention for ASD
|
TEACCH (Treatment and Education of Autistic and related Communication- handicapped Children) intervention or ABA(applied behavior analysis) intervention
|
EXPERIMENTAL: ADHD intervention
The early integrated intervention for ADHD
|
The methods of the early integrated intervention for ADHD includes behavior training, sensory integration training and psychological counseling
|
ACTIVE_COMPARATOR: ADHD non-intervention
Community intervention for ADHD
|
School and family education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline development quotient (DQ) in the Griffiths Development Scales-Chinese version at 1 year, 2 years for GDD and ASD
Time Frame: from enrollment to end of intervention (2 years). The DQ will be measured at the following time point: enrollment, 1 year, 2 years.
|
Griffiths Development Scales-Chinese version consists of 5 subscales, which are locomotor scale, personal-social scale, eye& hand coordination scale, hearing& language scale.
Each subscale has a development quotient.
The developmental ages (DA) are referred from the norms and developmental quotients (DQ) are calculated by DA/CA (chronological age)*100.
DQ for subscales have a mean of 100 (SD: 15).
Higher DQ represent a better outcome.
This is a repeate measurement
|
from enrollment to end of intervention (2 years). The DQ will be measured at the following time point: enrollment, 1 year, 2 years.
|
Change from baseline score of the Conners Early Childhood (Conners EC) at 1 year, 2 years for ADHD
Time Frame: from enrollment to end of intervention (2 years). The score of Conners EC will be measured at the following time point: enrollment, 1 year, 2 years.
|
The Conners Early Childhood (Conners EC) aids in the early identification of behavioral, social, and emotional problems.
It consists of 110 items.
According to the 110 items of Conners EC, parents score children's behavioral frequency based on daily observations.
The higher the score is, the more serious behavioral problems the children have.
This is a repeate measurement
|
from enrollment to end of intervention (2 years). The score of Conners EC will be measured at the following time point: enrollment, 1 year, 2 years.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline score of the Communication and Symbolic Behavior Scales Developmental Profile-Infant Toddler Checklist(CSBS-DP-ITC)at 1 year, 2 years for ASD
Time Frame: from enrollment to end of intervention (2 years). The score of CSBS-DP-ITC will be measured at the following time point: enrollment, 1 year, 2 years.
|
This is a parent-reported questionnaire widely used for screening communication disorders including ASD in infants and toddlers.
The whole scale consists of 24 items divided into three subscales (social, speech, and symbolic composite) and an open question at the end.
The changes in raw scores of each subscale and the whole scale partly reflect the change in social communication skills of children.This is a repeate measurement
|
from enrollment to end of intervention (2 years). The score of CSBS-DP-ITC will be measured at the following time point: enrollment, 1 year, 2 years.
|
Change from baseline intelligence quotient (IQ) in the Wechsler Intelligence Scale at 1 year, 2 years for ADHD
Time Frame: from enrollment to end of intervention (2 years). The IQ will be measured at the following time point: enrollment, 1 year, 2 years
|
Wechsler Intelligence Scale consists of 2 subscales, which are verbal scale and performance scale.
The intelligence quotient (IQ) are referred from the norms.
Higher IQ represent a better outcome.This is a repeate measurement
|
from enrollment to end of intervention (2 years). The IQ will be measured at the following time point: enrollment, 1 year, 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Xiu Xu, MD, PhD, Children's Hospital of Fudan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 15, 2018
Primary Completion (ACTUAL)
June 30, 2021
Study Completion (ACTUAL)
July 30, 2021
Study Registration Dates
First Submitted
February 11, 2019
First Submitted That Met QC Criteria
February 19, 2019
First Posted (ACTUAL)
February 20, 2019
Study Record Updates
Last Update Posted (ACTUAL)
January 11, 2022
Last Update Submitted That Met QC Criteria
January 6, 2022
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MBDZXGY2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on The early integrated intervention for GDD
-
Massachusetts General HospitalNational Institute on Drug Abuse (NIDA); Universidad Autonoma de Madrid; Hospital...CompletedSubstance Use (Drugs, Alcohol)United States, Spain
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch... and other collaboratorsCompletedOverall Functioning | Incremental Cost-effectiveness RatioNetherlands
-
Liverpool School of Tropical MedicineUniversity of Warwick; Ministry of Health and Population, Malawi; Research for... and other collaboratorsCompleted
-
Medical University of South CarolinaMayo ClinicTerminated
-
European Organisation for Research and Treatment...Not yet recruiting
-
University of SydneyNational Health and Medical Research Council, Australia; Newcastle UniversityUnknown
-
Oregon Research InstituteCompleted
-
Karolinska InstitutetThe Swedish Research CouncilCompletedCerebral Palsy | Gross Motor Development DelaySweden
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; London Health Sciences Centre; ProjectVideo...CompletedPsychotic Disorders | Schizophrenia
-
Duquesne UniversityUniversity of Washington; Virginia Commonwealth University; University of Delaware and other collaboratorsCompletedCerebral Palsy | Developmental Delay | Infant DevelopmentUnited States